LMBRD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.703400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.786600E-01
Normal-vs-Stage2
9.523000E-01
Normal-vs-Stage3
1.759220E-01
Normal-vs-Stage4
3.281800E-01
Stage1-vs-Stage2
1.200770E-01
Stage1-vs-Stage3
4.875700E-02
Stage1-vs-Stage4
8.214400E-01
Stage2-vs-Stage3
1.542980E-01
Stage2-vs-Stage4
1.063760E-01
Stage3-vs-Stage4
4.695700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.070600E-01
Normal-vs-AfricanAmerican
3.553200E-01
Normal-vs-Asian
7.874800E-01
Caucasian-vs-AfricanAmerican
1.570610E-01
Caucasian-vs-Asian
4.907000E-01
AfricanAmerican-vs-Asian
9.776200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.867800E-01
Normal-vs-Female
7.518600E-01
Male-vs-Female
1.972990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.361600E-01
Normal-vs-Age(41-60Yrs)
6.365800E-01
Normal-vs-Age(61-80Yrs)
9.667600E-01
Normal-vs-Age(81-100Yrs)
5.001400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.188000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.216800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.541180E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.597700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.472400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.231000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.092000E-01
Normal-vs-Daily Drinker
5.663800E-01
Normal-vs-Weekly Drinker
9.827800E-01
Normal-vs-Occasional Drinker
5.513200E-01
Normal-vs-Social Drinker
6.224600E-01
Non Drinker-vs-Daily Drinker
7.008200E-01
Non Drinker-vs-Weekly Drinker
5.626400E-01
Non Drinker-vs-Occasional Drinker
3.803900E-02
Non Drinker-vs-Social Drinker
1.566810E-01
Daily Drinker-vs-Weekly Drinker
4.020200E-01
Daily Drinker-vs-Occasional Drinker
2.696200E-02
Daily Drinker-vs-Social Drinker
1.174810E-01
Weekly Drinker-vs-Occasional Drinker
2.753600E-01
Weekly Drinker-vs-Social Drinker
3.222400E-01
Occasional Drinker-vs-Social Drinker
8.208200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.106800E-01
Normal-vs-Grade 2
2.266000E-01
Normal-vs-Grade 3
1.848170E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
3.518400E-01
Grade 1-vs-Grade 3
6.250400E-01
Grade 1-vs-Grade 4
3.106800E-01
Grade 2-vs-Grade 3
4.887600E-01
Grade 2-vs-Grade 4
2.266000E-01
Grade 3-vs-Grade 4
1.848170E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.729600E-01
Normal-vs-NonDiabetic
9.708600E-01
Diabetic-vs-NonDiabetic
5.838800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.871400E-01
Normal-vs-NoPancreatitis
9.288600E-01
Pancreatitis-vs-NoPancreatitis
1.634180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.192600E-01
Normal-vs-N1
9.249200E-01
N0-vs-N1
5.456000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.958400E-01
Normal-vs-TP53-NonMutant
5.137600E-01
TP53-Mutant-vs-TP53-NonMutant
1.905770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
